Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. FTRE
stocks logo

FTRE

-
Add to WatchlistAdvanced Chart
$
0.000
0(0.000%)1D
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
631.46M
-4.67%
0.075
-350.87%
611.16M
-9.44%
0.149
-35.35%
613.57M
-11.97%
0.210
+16.61%
Estimates Revision
The market is revising Downward the revenue expectations for Fortrea Holdings Inc. (FTRE) for FY2025, with the revenue forecasts being adjusted by -0.04% over the past three months. During the same period, the stock price has changed by -4.81%.
Revenue Estimates for FY2025
Revise Downward
down Image
-0.04%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.7%
In Past 3 Month
Stock Price
Go Down
down Image
-4.81%
In Past 3 Month
10 Analyst Rating
up Image0
Wall Street analysts forecast FTRE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FTRE is 5.97 USD with a low forecast of 4.75 USD and a high forecast of 8.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
8 Hold
2 Sell
Hold
up Image0
Current: 4.950
sliders
Low
4.75
Averages
5.97
High
8.00
up Image0
Current: 4.950
sliders
Low
4.75
Averages
5.97
High
8.00
Mizuho
Neutral
downgrade
$8 -> $7
2025-07-11
Reason
Mizuho
Price Target
$8 -> $7
2025-07-11
downgrade
Neutral
Reason
Mizuho lowered the firm's price target on Fortrea to $7 from $8 and keeps a Neutral rating on the shares as part of a Q2 earnings preview. The firm believes earnings visibility is solid for the hospital group while cost trends remain challenging for managed care companies. Mizuho says its survey of 215 physicians is positive for hospitals, neutral for clinical labs, and neutral-to-negative for managed care.
Citi
Neutral
maintain
$6
2025-05-22
Reason
Citi
Price Target
$6
2025-05-22
maintain
Neutral
Reason
Mizuho
Neutral
downgrade
$10 -> $8
2025-05-14
Reason
Mizuho
Price Target
$10 -> $8
2025-05-14
downgrade
Neutral
Reason
Mizuho lowered the firm's price target on Fortrea to $8 from $10 and keeps a Neutral rating on the shares. The company reported a good Q1 earnings beat, but reported weaker than expected bookings trends driven by delays in awards for biotech clients and soft demand in clinical pharmacology, the analyst tells investors in a research note. The firm expects the funding backdrop and volatile macroeconomic environment coupled with the loss of its CEO to continue to put pressure on Fortrea.
TD Cowen
Charles Rhyee
Hold
downgrade
$7 -> $5
2025-05-14
Reason
TD Cowen
Charles Rhyee
Price Target
$7 -> $5
2025-05-14
downgrade
Hold
Reason
TD Cowen analyst Charles Rhyee lowered the firm's price target on Fortrea to $5 from $7 and keeps a Hold rating on the shares. The firm updated estimates to reflect continued soft biotech and large pharma.
Barclays
Luke Sergott
Underweight
downgrade
$6 -> $5
2025-05-13
Reason
Barclays
Luke Sergott
Price Target
$6 -> $5
2025-05-13
downgrade
Underweight
Reason
Barclays analyst Luke Sergott lowered the firm's price target on Fortrea to $5 from $6 and keeps an Underweight rating on the shares. The company's CEO is stepping down and it reported a bookings miss on big sales beat, the analyst tells investors in a research note. The firm expects the shares to respond positively outside of commentary that things are getting materially worse.
Barclays
Luke Sergott
Hold
to
Sell
Downgrades
$12 → $6
2025-04-10
Reason
Barclays
Luke Sergott
Price Target
$12 → $6
2025-04-10
Downgrades
Hold
to
Sell
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Fortrea Holdings Inc (FTRE.O) is 9.57, compared to its 5-year average forward P/E of 28.91. For a more detailed relative valuation and DCF analysis to assess Fortrea Holdings Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
28.91
Current PE
9.57
Overvalued PE
45.52
Undervalued PE
12.30

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
13.25
Current EV/EBITDA
8.86
Overvalued EV/EBITDA
17.14
Undervalued EV/EBITDA
9.37

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
0.74
Current PS
0.18
Overvalued PS
1.04
Undervalued PS
0.44

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

FTRE News & Events

Events Timeline

(ET)
2025-06-24
07:06:13
Fortrea announces strategic collaboration with Emery Pharma
select
2025-06-12 (ET)
2025-06-12
08:42:18
Fortrea adopts limited-duration stockholder rights plan
select
2025-06-11 (ET)
2025-06-11
16:13:22
Fortrea names Anshul Thakral as CEO
select
Sign Up For More Events
Sign Up For More Events

News

Preview
7.0
07-17Globenewswire
Levi & Korsinsky Reminds Fortrea Holdings Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 1, 2025 – FTRE

  • Class Action Lawsuit: A class action securities lawsuit has been filed against Fortrea Holdings Inc. for alleged securities fraud affecting investors between July 3, 2023, and February 28, 2025, claiming the company made false statements regarding its revenue projections and financial prospects.

  • Investor Participation: Investors who suffered losses during this period can request to be appointed as lead plaintiff by August 1, 2025, with no out-of-pocket costs required to participate in the lawsuit.

Preview
7.0
07-16Globenewswire
מועד אחרון לתביעה נגד  FTRE: רוזן, משרד עורכי דין מוביל, מעודד משקיעים ב- Fortrea Holdings, Inc.  עם הפסדים של יותר מ- 100 אלף דולר, להבטיח ייעוץ לפני המועד האחרון החשוב בתביעה ייצוגית בניירות ערך – FTRE

  • Class Action Lawsuit Announcement: The Rosen Law Firm is reminding investors who purchased securities of Fortrea Holdings, Inc. between July 3, 2023, and February 28, 2025, that they may be eligible for compensation without deductibles or costs under a class action lawsuit, with a deadline to join by August 1, 2025.

  • Allegations Against Fortrea: The lawsuit claims that Fortrea made false and misleading statements regarding its revenue projections and cost savings, leading to inflated EBITDA targets and causing investor losses when the truth was revealed.

Preview
7.0
07-16PRnewswire
Lawsuit Alert: Investors who lost money with Fortrea Holdings Inc. (NASDAQ: FTRE) should contact the Shareholders Foundation

  • Lawsuit Announcement: A lawsuit is pending against Fortrea Holdings Inc. (NASDAQ: FTRE) for alleged securities law violations, with claims that the company misrepresented its revenue projections and financial prospects prior to July 2023.

  • Investor Contact Information: Shareholders who purchased shares of Fortrea Holdings Inc. are encouraged to contact the Shareholders Foundation for options regarding their investments and to learn more about the ongoing legal proceedings.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Fortrea Holdings Inc (FTRE) stock price today?

The current price of FTRE is 4.95 USD — it has increased 1.02 % in the last trading day.

arrow icon

What is Fortrea Holdings Inc (FTRE)'s business?

Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

arrow icon

What is the price predicton of FTRE Stock?

Wall Street analysts forecast FTRE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FTRE is 5.97 USD with a low forecast of 4.75 USD and a high forecast of 8.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Fortrea Holdings Inc (FTRE)'s revenue for the last quarter?

Fortrea Holdings Inc revenue for the last quarter amounts to 651.30M USD, decreased -1.63 % YoY.

arrow icon

What is Fortrea Holdings Inc (FTRE)'s earnings per share (EPS) for the last quarter?

Fortrea Holdings Inc. EPS for the last quarter amounts to -6.25 USD, increased 453.10 % YoY.

arrow icon

What changes have occurred in the market's expectations for Fortrea Holdings Inc (FTRE)'s fundamentals?

The market is revising Downward the revenue expectations for Fortrea Holdings Inc. (FTRE) for FY2025, with the revenue forecasts being adjusted by -0.04% over the past three months. During the same period, the stock price has changed by -4.81%.
arrow icon

How many employees does Fortrea Holdings Inc (FTRE). have?

Fortrea Holdings Inc (FTRE) has 15500 emplpoyees as of July 18 2025.

arrow icon

What is Fortrea Holdings Inc (FTRE) market cap?

Today FTRE has the market capitalization of 447.98M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free